When did OLEMA PHARMACEUTICALS INC (OLMA) report earnings last quarter?
OLEMA PHARMACEUTICALS INC (OLMA) last reported earnings on 3/16/2026.
NASDAQ:OLMA • US68062P1066
Past quarterly earnings results for OLEMA PHARMACEUTICALS INC (OLMA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.50 | -0.54 | 7.28% | 1.96% | - | - | ||
| Q3 2025 | -0.49 | -0.49 | 0.67% | 18.33% | - | - | ||
| Q2 2025 | -0.51 | -0.38 | -32.98% | 5.56% | - | - | ||
| Q1 2025 | -0.36 | -0.52 | 30.80% | 35.71% | - | - | ||
| Q4 2024 | -0.51 | -0.65 | 21.88% | -4.08% | - | - | ||
| Q3 2024 | -0.60 | -0.59 | -1.80% | -25.00% | - | - | ||
| Q2 2024 | -0.54 | -0.57 | 4.46% | -10.20% | - | - | ||
| Q1 2024 | -0.56 | -0.56 | -0.58% | 20.00% | - | - | ||
| Q4 2023 | -0.49 | -0.49 | 0.10% | 24.62% | - | - | ||
| Q3 2023 | -0.48 | -0.52 | 7.95% | 15.79% | - | - | ||
| Q2 2023 | -0.49 | -0.74 | 33.93% | 40.24% | - | - | ||
| Q1 2023 | -0.70 | -0.68 | -3.46% | -20.69% | - | - | ||
| Q4 2022 | -0.65 | -0.67 | 2.26% | -20.37% | - | - | ||
| Q3 2022 | -0.57 | -0.78 | 27.24% | -26.67% | - | - | ||
| Q2 2022 | -0.82 | -0.65 | -25.22% | -95.24% | - | - | ||
| Q1 2022 | -0.58 | -0.58 | 0.24% | -48.72% | - | - | ||
| Q4 2021 | -0.54 | -0.50 | -6.95% | -8.00% | - | - | ||
| Q3 2021 | -0.45 | -0.47 | 3.25% | - | - | - | ||
| Q2 2021 | -0.42 | -0.39 | -8.36% | - | - | - | ||
| Q1 2021 | -0.39 | -0.29 | -36.55% | - | - | - | ||
| Q4 2020 | -0.50 | -0.18 | -177.46% | - | - | - | ||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
OLEMA PHARMACEUTICALS INC (OLMA) last reported earnings on 3/16/2026.
OLEMA PHARMACEUTICALS INC (OLMA) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, OLEMA PHARMACEUTICALS INC (OLMA) has beaten EPS estimates in 3 out of 4 releases.